Drug Shortage Report for JANUVIA
Report ID | 179856 |
Drug Identification Number | 02303922 |
Brand name | JANUVIA |
Common or Proper name | sitagliptin tablets (as sitagliptin phosphate monohydrate) |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SITAGLIPTIN |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | A10BH |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-01-04 |
Actual start date | 2023-01-04 |
Estimated end date | 2023-01-27 |
Actual end date | 2023-01-25 |
Shortage status | Resolved |
Updated date | 2023-01-26 |
Company comments | 100 tab format is available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-01-26 | French | Compare |
v5 | 2023-01-25 | French | Compare |
v4 | 2023-01-25 | English | Compare |
v3 | 2023-01-05 | English | Compare |
v2 | 2023-01-04 | French | Compare |
v1 | 2023-01-04 | English | Compare |
Showing 1 to 6 of 6